Skip to content
  • There are no suggestions because the search field is empty.
nav-feature_csa-monitor

Check Out Our Latest Product Release

CSA Monitor tracks your driver and risk data in real time.

Learn More
nav-feature_dash

Reach Your Business Goals with Dash

Foley's customizable platform for your unique initiatives.

Learn More
nav-feature_resources

New Resources Waiting for You & Your Team

Expert, always-free resources at your fingertips.

Learn More
Drug Positivity Rates are on the Rise
Scott Mogensen
3 mins read

 

Opioid abuse has skyrocketed since the COVID pandemic started a year ago. According to a recent study by Quest Diagnostics Health Trends, there has been a 35 percent increase in the use of non-prescribed fentanyl and a 44 percent increase in heroin use. Abuse of other non-prescribed opioids has increased by 10 percent.

 

Upgrade to an EASY DOT Drug Testing Program -  Contact Us Today!

This report came on the heels of the annual Quest Workplace Study which actually showed a decrease in opioid use in 2019. While good news, many experts believed the trend would be short-lived given the stress and isolation of the pandemic – and it seems like they were right. Not only are these triggers for new opioid abuse cases, but recovering addicts have been struggling to maintain the support needed to prevent a relapse.

In addition, data from the Centers for Disease Control and Prevention show that new drug abuse cases have increased by 13.3 percent as a result of COVID-related stress and loneliness.

Drug Use Up – Testing Down

In addition to a sharp increase in drug positivity rates post-COVID, the Quest study found another disturbing trend: a sharp decline in the number of drug tests being conducted. In the early months of the pandemic, when lockdowns and social distancing took effect nationwide, there were up to 70 percent fewer drug tests being ordered on a weekly basis.

This is something we witnessed in the transportation industry in the early part of last year, with some safety-sensitive employers having a difficult time meeting all of their DOT drug testing requirements because of collection site closures.

Yet with such a sharp increase in opioid use, sending drivers for these tests may never have been more important.

Maintaining a Drug-Free Workplace

Although all of your DOT-regulated employees will be enrolled in a random testing program, if you have non-safety sensitive employees at your workplace, you might consider enrolling them in a Drug-Free Workplace program to discourage recreational drug use among all your employees. With drug use associated with higher absenteeism and workplace accidents, having a process in place to randomly test employees will help you maintain a safer, more productive workforce. To learn more about drug-free workplace programs and the benefits for your company, please give us a call at (800) 253-5506 or click here for more information.

 
×
Fill out this form and a member of our team will reach out shorty.

Schedule a demo to see Dash in action.
A Foley expert is ready to help your company create a streamlined hiring, screening, and onboarding process that's easier for your candidate and team, while keeping you compliant with DOT and FMCSA requirements. Fill out this form, and we'll schedule a time for a personalized online demo of Dash.

FORM IMAGE (1)
Whether you’re looking for a quick background check, or a comprehensive DOT compliance solution, Foley can help.